Angel M. Carcaboso

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

The clinical and molecular landscape of thalamic glioma.

The clinical and molecular landscape of thalamic glioma.

Journal: Neuro-oncology

Published: January 24, 2026

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Journal: Cancer research

Published: November 19, 2025

Consequences of irradiation on blood-brain tumor barrier model of Diffuse Midline Glioma: characterization of physical and metabolic properties.

Consequences of irradiation on blood-brain tumor barrier model of Diffuse Midline Glioma: characterization of physical and metabolic properties.

Journal: Fluids and barriers of the CNS

Published: September 16, 2025

Characterization of patient-derived site-specific in vivo models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging.

Characterization of patient-derived site-specific in vivo models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging.

Journal: Neuro-oncology advances

Published: September 09, 2025

Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma.

Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma.

Journal: Neuro-oncology advances

Published: July 24, 2025

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.

Journal: NPJ precision oncology

Published: July 23, 2025

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.

Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.

Journal: NPJ precision oncology

Published: July 23, 2025

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Journal: The Journal of molecular diagnostics : JMD

Published: April 08, 2025

Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline glioma.

Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline glioma.

Journal: Scientific reports

Published: March 20, 2025

Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs.

Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs.

Journal: Investigative ophthalmology & visual science

Published: December 05, 2024

Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.

Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.

Journal: Journal of neuro-oncology

Published: December 02, 2024

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.

Journal: Journal for immunotherapy of cancer

Published: September 16, 2024

Showing 1-12 of 109

Last Updated: 09/26/2026